BrainCool AB (publ) Receives US FDA De Novo Clearance for the Cooral® System for Reduction of Oral Mucositis
The market clearance paves the way for reduction of one of the most severe side-effects of chemotherapy, Oral Mucositis (OM). ANNAPOLIS, MARYLAND, UNITED STATES, November 1, 2022 /EINPresswire.com/ -- BrainCool Inc a subsidiary of the Swedish medical …